Key role for respiratory CD103+ dendritic cells, IFN-, and IL-17 in protection against streptococcus pneumoniae infection in response to-galactosylceramide

Journal of Infectious Diseases

Volumn 206, Issue 5, 2012, Pages 723-734

  Ivanov, Stoyan ^a,b,c,d   Fontaine, Josette ^a,b,c,d   Paget, Christophe ^a,b,c,d   MacHo Fernandez, Elodie ^a,b,c,d   Van Maele, Laurye ^a,b,c,d   Renneson, Joelle ^a,b,c,d   Maillet, Isabelle ^e   Wolf, Natalia Muñoz ^f   Rial, Analia ^g   Léger, Hélène ^f   Ryffel, Bernard ^e   Frisch, Benoit ^f   Chabalgoity, José A ^g   Sirard, Jean Claude ^a,b,c,d   Benecke, Arndt ^f   Faveeuw, Christelle ^a,b,c,d   Trottein, François ^a,b,c,d  

^a INSERM U1019   (France)

^b UNIV LILLE   (France)

^c INSERM   (France)

^d Institut Federatif de Recherche 142   (France)

^e UNIVERSITÉ D'ORLÉANS   (France)

^f CNRS   (France)

^g Universidad de la Republica Instituto de Higiene   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 17;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; MALE; MICROARRAY ANALYSIS; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIGENS, CD; BRONCHOALVEOLAR LAVAGE FLUID; DENDRITIC CELLS; GALACTOSYLCERAMIDES; IMMUNITY, INNATE; INTEGRIN ALPHA CHAINS; INTERFERON-GAMMA; INTERLEUKIN-17; KAPLAN-MEIER ESTIMATE; MALE; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; PNEUMOCOCCAL INFECTIONS; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE;

EID: 84864915944     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis413     Document Type: Article

References (49)

1. Klugman KP, Feldman C. Streptococcus pneumoniae respiratory tract infections. Curr Opin Infect Dis 2001; 14:173-9. (Pubitemid 32231103)
2. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374:1543-56.
3. Rial A, Lens D, Betancor L, Benkiel H, Silva JS, Chabalgoity JA. Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses. Infect Immun 2004; 72:2679-88. (Pubitemid 38542394)
4. Munoz N, Van Maele L, Marques JM, Rial A, Sirard JC, Chabalgoity JA. Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection. Infect Immun 2010; 78:4226-33.
5. Clement CG, Evans SE, Evans CM, et al. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am J Respir Crit Care Med 2008; 177:1322-30. (Pubitemid 351860909)
6. Barral DC, Brenner MB. CD1 antigen presentation: how it works. Nat Rev Immunol 2007; 7:929-41. (Pubitemid 350166056)
7. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25:297-336. (Pubitemid 46697911)
8. Cerundolo V, Silk JD, Masri SH, Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 2009; 9:28-38.
9. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004; 114:1379-88. (Pubitemid 40385565)
10. Van Kaer L, Joyce S. Innate immunity: NKT cells in the spotlight. Curr Biol 2005; 15:R429-31. (Pubitemid 40772144)
11. Michel ML, Keller AC, Paget C, et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007; 204:995-1001. (Pubitemid 46798144)
12. Coquet JM, Chakravarti S, Kyparissoudis K, et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc Natl Acad Sci USA 2008; 105:11287-92.
13. Cohen NR, Garg S, Brenner MB. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol 2009; 102:1-94.
14. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000; 30:122-40. (Pubitemid 30067070)
15. Bialecki E, Paget C, Fontaine J, Capron M, Trottein F, Faveeuw C. Role of marginal zone B lymphocytes in invariant NKT cell activation. J Immunol 2009; 182:6105-13.
16. van Rooijen N, van Nieuwmegen R. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res 1984; 238:355-8. (Pubitemid 14025016)
17. Cui J, Shin T, Kawano T, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278:1623-6. (Pubitemid 27516281)
18. Jung S, Unutmaz D, Wong P, et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cellassociated antigens. Immunity 2002; 17:211-20. (Pubitemid 35245963)
19. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colonystimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194:519-27. (Pubitemid 32835046)
20. Paget C, Ivanov S, Fontaine J, et al. Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia. J Immunol 2011; 186:5590-602.
21. Paget C, Mallevaey T, Speak AO, et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007; 27:597-609. (Pubitemid 47628833)
22. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR. CD1 recognition by mouse NK1+ T lymphocytes. Science 1995; 268:863-5.
23. Zemlickova H, Crisostomo MI, Brandileone MC, et al. Serotypes and clonal types of penicillin-susceptible Streptococcus pneumoniae causing invasive disease in children in five Latin American countries. Microb Drug Resist 2005; 11:195-204. (Pubitemid 41434163)
24. Marques JM, Rial A, Munoz N, et al Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17-and IFN-gamma-mediated immunity. Immunobiology 2012; 78:420-29.
25. Van Maele L, Carnoy C, Cayet D, et al. TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa. J Immunol 2010; 185:1177-85.
26. Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119:3544-55.
27. Wilhelm E, Kornete M, Targat B, et al. TAF6delta orchestrates an apoptotic transcriptome profile and interacts functionally with p53. BMC Mol Biol 2010; 11:10.
28. Chiba A, Dascher CC, Besra GS, Brenner MB. Rapid NKT cell responses are self-terminating during the course of microbial infection. J Immunol 2008; 181:2292-302.
29. Kim HY, Kim S, Chung DH. FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation. J Clin Invest 2006; 116:2484-92. (Pubitemid 44330147)
30. Hobbs JA, Cho S, Roberts TJ, et al. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J Virol 2001; 75:10746-54. (Pubitemid 33031544)
31. Lin Y, Roberts TJ, Wang CR, Cho S, Brutkiewicz RR. Long-term loss of canonical NKT cells following an acute virus infection. Eur J Immunol 2005; 35:879-89. (Pubitemid 40425544)
32. del Rio ML, Rodriguez-Barbosa JI, Kremmer E, Forster R. CD103-and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8 + T cells. J Immunol 2007; 178:6861-6. (Pubitemid 46847411)
33. Sung SS, Fu SM, Rose CE Jr, Gaskin F, Ju ST, Beaty SR. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 2006; 176:2161-72. (Pubitemid 43201663)
34. Garvy BA, Harmsen AG. The importance of neutrophils in resistance to pneumococcal pneumonia in adult and neonatal mice. Inflammation 1996; 20:499-512. (Pubitemid 26361653)
35. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141:471-501. (Pubitemid 20068893)
36. Standiford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol 1996; 59:24-8. (Pubitemid 26054589)
37. Kawakami K, Yamamoto N, Kinjo Y, et al. Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 2003; 33:3322-30. (Pubitemid 37541108)
38. Nakamatsu M, Yamamoto N, Hatta M, et al. Role of interferongamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect 2007; 9:364-74. (Pubitemid 46350859)
39. Scanlon ST, Thomas SY, Ferreira CM, et al. Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J Exp Med 2011; 208:2113-24.
40. Barletta KE, Cagnina RE, Wallace KL, Ramos SI, Mehrad B, Linden J. Leukocyte compartments in the mouse lung: distinguishing between marginated, interstitial, and alveolar cells in response to injury. J Immunol Methods 2012; 375:100-110.
41. Courtney AN, Thapa P, Singh S, Wishahy AM, Zhou D, Sastry J. Intranasal but not intravenous delivery of the adjuvant alpha-galactosylceramide permits repeated stimulation of natural killer T cells in the lung. Eur J Immunol 2011; 41:3312-22.
42. Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009; 31:412-24.
43. Condon TV, Sawyer RT, Fenton MJ, Riches DW. Lung dendritic cells at the innate-adaptive immune interface. J Leukoc Biol 2011; 90:883-95.
44. Kim EY, Battaile JT, Patel AC, et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008; 14:633-40. (Pubitemid 351809546)
45. Nieuwenhuis EE, Matsumoto T, Exley M, et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002; 8:588-93. (Pubitemid 34633436)
46. Kim BH, Shenoy AR, Kumar P, Das R, Tiwari S, MacMicking JD. A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Science 2011; 332:717-21.
47. Martens S, Howard J. The interferon-inducible GTPases. Annu Rev Cell Dev Biol 2006; 22:559-89.
48. Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008; 4:e1000159.
49. Lee KA, Kang MH, Lee YS, et al. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. Cell Immunol 2008; 251:50-5.